Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint

Activity ID

3065

Expires

December 31, 2021

Format Type

Internet

CME Credit

Fee

CME Provider

University of North Texas Health Science Center

Description

Physicians across many specialties manage acute and chronic pain in their patients on a daily basis. However, gaps in pain care for many physicians exist due to time limitations and lack of training in pain management.

With the many issues related to pharmacologic therapies for pain (i.e. misuse and noncompliance, addiction, adverse effects, tolerance, and polypharmacy), physicians are duly concerned. It is challenging for physicians to stay current with emerging evidence on abuse-deterrent formulations of opioid medications. Clinicians may feel uncomfortable communicating with patients about the issue of misuse and may not be prepared to make use of the prescription-drug-monitoring programs available to assist in identifying opioid misuse.

Presenting clinicians with a thorough review of the FDA’s “Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain” will allow them to provide evidence-based pain management to their patients on a daily basis. The activity will also provide tools to help clinicians mitigate issues associated with opioid therapies, i.e. misuse and addiction, and take steps to avert the opioid addiction crisis.

ABMS Member Board Approvals by Type

ABMS MOC Part II Self-Assessment Activity

Physical Medicine and Rehabilitation

ABMS MOC Part II CME Activity

Allergy and Immunology

Anesthesiology

Family Medicine

Medical Genetics and Genomics

Nuclear Medicine

Physical Medicine and Rehabilitation

Preventive Medicine

Psychiatry and Neurology

Radiology

Thoracic Surgery

Urology

More Information

Commercial Support?

Yes

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

General Information

Educational Objectives

1. Define components of an effective treatment plan, such as treatment goals, patient engagement, and collaboration within the healthcare team
2. Assess the risks and benefits of non-pharmacologic therapies prior to initiating long-term pharmacologic therapy
3. Identify patients who are candidates for treatment with nonopioid pharmacologic analgesics
4. Evaluate criteria for initiating opioid analgesic
5. Identify risk factors for addiction to opioid analgesics

Keywords

Opioids, Risk Assessment, Pain Management

Competencies

Interpersonal & Communication Skills, Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Opioid REMS

This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies.

MIPS Approved

This activity qualifies for the CMS Merit-based Incentive Payment System (MIPS), where you can earn a performance-based payment adjustment to your Medicare payment

Practice Setting

Academic Medicine, Inpatient, Outpatient, Physician Executives, Physician Scientists, Rural, Urban, VA/Military